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Two-component systems (TCSs) have the potential to be an effective target of
the antimicrobials, and thus received much attention in recent years. VicK/VicR is
one of TCSs in Streptococcus pneumoniae (S. pneumoniae), which is essential for
pneumococcal survival. Wehavepreviouslyobtainedseveral TraditionalChineseMedicine
monomers using a computer-based screening. In this study, either alone or in combination
with penicillin, their antimicrobial activities were evaluated based on in vivo and in vitro
assays. The results showed that the MICs of 5′-(Methylthio)-5′-deoxyadenosine, octanal
2, 4-dinitrophenylhydrazone, deoxyshikonin, kavahin, and dodecyl gallate against S.
pneumoniae were 37.1, 38.5, 17, 68.5, and 21µg/mL, respectively. Time-killing assays
showed that these compounds elicited bactericidal effects against S. pneumoniae D39
strain, which led to a 6-log reduction in CFU after exposure to compounds at four times of
the MIC for 24 h. The five compounds inhibited the growth of Streptococcus pyogenes,
Streptococcus mitis, Streptococcus mutans or Streptococcus pseudopneumoniae,
meanwhile, deoxyshikonin and dodecyl gallate displayed strong inhibitory activities
against Staphylococcus aureus. These compounds showed no obvious cytotoxicity
effects on Vero cells. Survival time of the mice infected by S. pneumoniae strains was
prolonged by the treatment with the compounds. Importantly, all of the five compounds
exerted antimicrobial effects against multidrug-resistant clinical strains of S. pneumoniae.
Moreover, evenat sub-MICconcentration, they inhibited cell division andbiofilm formation.
The five compounds all have enhancement effect on penicillin. Deoxyshikonin anddodecyl
gallate showed significantly synergic antimicrobial activity with penicillin in vivo and
in vitro, and effectively reduced nasopharyngeal and lung colonization caused by different
penicillin-resistantpneumococcal serotypes. Inaddition, the twocompoundsalsoshowed
synergic antimicrobial activity with erythromycin and tetracycline. Taken together, our
results suggest that these novel VicK inhibitors may be promising compounds against the
pneumococcus, including penicillin-resistant strains.
Keywords: Streptococcus pneumoniae, Traditional Chinese Medicine monomer, antimicrobial, histidine kinase,
VicK protein
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Introduction
Invasive pneumococcal infections, such as pneumonia,
sepsis, and meningitis, commonly have high morbidity
and mortality worldwide (Bandettini and Melioli, 2012).
In recent years, the emergence of multidrug-resistant
and vancomycin-resistant strains has become increasingly
frequent because of the antibiotics abuse in hospitals
(Hanna-Wakim et al., 2012). Therefore, the development
of novel antimicrobials against pneumococcal infections is
indispensable.
Two-component systems (TCS) are deserved to be considered
as effective drug targets, because they are required for the
regulation of bacterial virulence and growth (Barrett and Hoch,
1998; Fabret and Hoch, 1998) and TCSs have not been found in
mammals (Worthington et al., 2013). TCSs are composed of a
sensor kinase (histidine kinase, HK) and a response regulator.
Compared with drugs that target the sensory domains of HKs,
those that target the conserved catalytic domains of HKs which
could coordinately inhibit multiple TCSs are expected to reduce
the virulence of pathogenic microorganisms more efficiently
(Gotoh et al., 2010). Yamamoto and Watanabe (Yamamoto
et al., 2001; Watanabe et al., 2003) have verified that HK
inhibitors, such as synthetic imidazole, zerumbone derivatives,
and aranorosinol B, were effective antibacterial agents against
Bacillus subtilis.
VicK/VicR is conserved and specific to low G+C Gram-
positive bacteria. It has been reported that VicK/VicR is essential
for the survival of pathogens, such as Streptococcus pneumoniae
(S. pneumoniae) (Wayne et al., 2012) and Staphylococcus
epidermidis (S. epidermidis) (Qin et al., 2007). Qin et al. has
previously reported that seven compounds showed antibacterial
activities against S. epidermidis strains by targeting VicK
in vitro (Qin et al., 2006). We have also previously obtained
six synthetic compounds with effective antibacterial activity
that targeted the ATPase domain of VicK in S. pneumoniae
(Li et al., 2009).
Traditional Chinese Medicine (TCM) may be an important
source of new drugs. We have previously used a structure-
based virtual screening method to screen the natural TCM
monomers with the ability to interact with VicK protein by
targeting the VicK HATPase_c domain, and the screening
procedure was essentially performed according to our previous
established method except the change in drug database (Li
et al., 2009). A total of 96 natural TCM monomers were
identified as potential inhibitors of the VicK protein. In the
present study, five compounds were identified as VicK inhibitors.
They were 5′-(Methylthio)-5′-deoxyadenosine, octanal 2, 4-
dinitrophenylhydrazone, deoxyshikonin, kavahin, and dodecyl
gallate. 5′-(Methylthio)-5′-deoxyadenosine is extracted from
Saccharomyce scerevisiae. Octanal 2, 4-dinitrophenylhydrazone
is the compound from extracts of a variety of plants such
as honeysuckle. Deoxyshikonin, an extract from the roots
Abbreviations: TCM, Traditional Chinese Medicine; PEN, penicillin; MIC,
minimal inhibitory concentration; TCS, Two-component systems; PRSP,
penicillin-resistant S. pneumoniae; MRSA, methicillin-resistant Staphylococcus
aureus.
of Maharanga, was identified to exhibit anticancer activity
(Rajasekar et al., 2012). And kavahin, extracted from the root of
kava, was reported as an analgesic agent (Kormann et al., 2012).
To the best of our knowledge, there is no related report about the
antibacterial activity of these 4 compounds. Only dodecyl gallate
has been reported as an antibacterial agent against methicillin-
resistant Staphylococcus aureus (MRSA) (Kubo et al., 2003), but it
remains unknown whether dodecyl gallate has antibacterial effect
against other bacteria.
In this study, the five compounds were primarily tested
for their efficacies against pneumococcal strains including
penicillin (PEN)-resistant S. pneumoniae (PRSP), and their MIC
concentrations were determined. To investigate whether they
have a broad antibacterial effect, the five compounds were tested
for their efficacies against MRSA and other streptococci. Their
efficacies against pneumococcal infections were also evaluated in
mouse sepsis models and local infection models. In addition, the
mechanism involved in the antibacterial effect was explored.
Materials and Methods
Bacterial Strains and Plasmids
The strains and plasmids used in this study are listed in Table 1.
Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)
strains were grown in LB medium. S. pneumoniae strains were
grown in C+Y medium at 37◦C in 5% CO2. Other streptococci
strains were grown in THB medium.
Traditional Chinese Medicine Monomer
5′-(Methylthio)-5′-deoxyadenosine (CAS: 2457-80-9), octanal 2,
4-dinitrophenylhydrazone (CAS: 1726-77-8), and dodecyl gallate
(CAS: 1166-52-5) were purchased from Sigma. Deoxyshikonin
(CAS: 43043-74-9) and kavahin (CAS: 495-85-2) were purchased
from J&K Scientific and Tautobiotech, respectively. Stock
solutions of the monomers were prepared in dimethyl sulfoxide
(DMSO). The structural formulas of the monomers are listed in
Figure 1.
Cytotoxicity Assay
The cytotoxicity of the drugs to Vero cells (African green
monkey kidney cells) was detected as previously described
(Huang et al., 2012) with minor modifications. In 96-well cell
culture plates, the cells (∼103 cells per well) were exposed to
the serially diluted drugs for 48 h. Then, relative cell numbers
were assayed by co-incubation with 3-(4, 5-dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide for 4 h at 37◦C in 5%
CO2. Purple formazan salts were dissolved with DMSO after
incubation. The absorbance of each well was measured at 595 nm
and then converted to percentages of the control (cells treated
with 1% DMSO). The concentration of the derivatives with 50%
cytotoxicity for Vero cells (CC50) was calculated using GraphPad
Prism 5 (San Diego, CA).
Inhibition Assay for ATPase Activity
The inhibitory activities of the Chinese medicine monomers
for the ATPase activity of the full-length VicK protein were
evaluated using the Kinase-Glo™Luminescent Kinase Assay
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant characteristics Source or reference
STRAINS
E. coli
BL21 (DE3) F ompT hsdSB (rBmB) gal dcm (DE3) Novagen
S. pneumoniae
NCTC7466 (D39) S. pneumoniae reference strain National Collection of Type Cultures (London, UK)
CMCC31109 Serotype 1 National Center for Medical Culture Collections (CMCC Beijing, China)
CMCC31203 Serotype 3
CMCC31207 Serotype 6B
CMCC31446 Serotype 4
CMCC31614 Serotype 14
CMCC31689 Serotype 19A
CMCC31693 Serotype 19F
Clinical isolates (34)
Streptococcus pyogenes Clinical isolates Children’s hospital, Chongqing, China
Streptococcus mitis Clinical isolates
Streptococcus mutans Clinical isolates
Streptococcus pseudopneumoniae Clinical isolates
S. aureus
ATCC29213 S. aureus reference strain American type culture collection (Maryland, USA)
Clinical isolates (3) Children’s hospital, Chongqing, China
PLASMIDS
pEVP3 Lee and Morrison, 1999
pEVP3-ftsW Yan et al., 2013
(Promega, Madison, USA). Briefly, 6µg VicK protein was
pre-incubated with a series of dilution of compounds in the
reaction buffer at 37◦C for 30min. 5µM ATP was added and
incubated for another 30min. Kinase-Glo™Reagent was also
added to detect the remaining ATP recorded from luminescence
measurements (RLU). In parallel, the VicK protein with no
addition of compounds was used as a control, and the mixture
with compounds excluding the VicK protein served as another
control. The rate of protein phosphorylation (Rp) inhibition by
the compounds was calculated from Equation (1).
Rp = 1− RLU(compound+ ATP+ Reagent)
− RLU(compound+ ATP+ vick+ Reagent)/RLU(ATP
+ Reagent)− RLU(ATP+ vick+ Reagent)× 100%
The half maximal inhibitory concentration (IC50), which
is the concentration of inhibition of 50% VicK protein
autophosphorylation, was determined by GraphPad Prism 5 (Qin
et al., 2006).
Antimicrobial Susceptibility Testing
Minimum inhibitory concentration (MIC) assays for the
antibacterial activities of the compounds were performed
according to the standard agar dilution method of the Clinical
and Laboratory Standards Institute of America. MIC testing
of drug-resistant S. pneumoniae, drug-resistant S. aureus,
streptococci and antimicrobial combination was also performed
using the same method. Briefly, the drugs were serially diluted
2-fold into eight wells with C+Y medium, yielding final
concentrations ranging from 2000 to 1.5µM. Then 106 CFU
bacteria were added to each well. Inoculated medium containing
1% DMSO served as a bacterial growth control, whereas
uninoculated medium served as a sterility control. The plates
were incubated at 37◦C for 12–16 h. The lowest concentration
that completely inhibits visible growth of the organism as
detected by the unaided eye was recorded as theMIC (Giacometti
et al., 2000). The experiment was repeated three times.
For time-kill assays, the organisms were cultured at 37◦C for
1 h and then treated with the drugs at one-fourth, one, and four
times the MIC. Viable cells were counted at 0, 2, 4, 6, 8, and 24 h
after the addition of the compounds (Mun et al., 2013).
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FIGURE 1 | The structures of the five compounds. Compound 1,
5′-(Methylthio)-5′-deoxyadenosine; Compound 2, Octanal 2,
4-dinitrophenylhydrazone; Compound 3, Deoxyshikonin; Compound 4,
Kavahin; Compound 5, Dodecyl gallate.
Determination of the In Vitro Effects of
Combinations of Antimicrobial Agents
The antimicrobial effects of different combinations of two
antimicrobial agents were assayed using the checkerboard test
(Bajaksouzian et al., 1997). Each experiment was repeated thrice.
The in vitro interaction between the five drugs with PEN was
quantified by the fractional inhibitory concentration (FIC). The
FIC index (FICI) was calculated using the following formula:
FIC = FICA + FICB = [A]/MICA + [B]/MICB
where [A] and [B] are the concentrations of drugs A and B,
respectively; MICA and FICA are the MIC and FIC of drug A
for the organism, respectively; and MICB, and FICB are the MIC
and FIC of drug B for the organism, respectively. The FIC index
obtained was interpreted as follows: =0.5, synergy; FIC > 2.0,
antagonism (Gupta and Kohli, 2003).
Biofilm-Killing Assays
Biofilm formation was detected using a semiquantitative plate
assay (Moscoso et al., 2006). 106 CFU of D39 was incubated
in C+Y medium for 6 h in a 96-well plate at 37◦C. Then
removed the planktonic cells, fresh C+Y medium containing the
serially diluted drugs was added to each well and incubated for
another 12 h at 37◦C. The wells were washed gently three times
with phosphate-buffered saline (PBS) and then stained with 1%
(w/v) crystal violet. 200µL methanol was added to dissolve the
precipitate and determine the absorbance of the wells at 590 nm
using a spectrophotometer (DTX880, Beckman Coulter, USA).
The values of biofilm formation were normalized for absorbance,
and the percentages were calculated in relation to control. The
experiment was repeated twice.
Cell Division Phenotype Assays
Phenotype assays were performed as previously described.
Briefly, overnight bacterial cultures were used for inoculation
(1:1000 dilutions). Then, 150µL aliquots were added to 96-
well microtiter plates containing dilutions of each compound
in 50µL volumes of medium. After incubation for 5 h at
37◦C, 10µL cultures were blotted to glass slides and then
stained with leather blue dye solution for microscopic analysis.
For Transmission electron microscopy (TEM), bacteria were
collected by centrifugation at 4◦C for 10min at 10,000
g. Precipitates were fixed in 2% glutaraldehyde in sodium
cacodylate buffer (pH 7.4) for 12 h and then processed by the
Electron Microscopy Research Service of Chongqing Medical
University. For visualization, cells were imaged with a Hitachi
H-7500 transmission electron microscopy.
β-Galactosidase Reporter Gene Assay
S. pneumoniae D39 and D39-pEVP3-fstW containing
FtsW::LacZ fusion were cultured in C+Y medium until
OD600 = 0.5–0.6. Subsequently, 10
7 CFU bacteria were collected
by centrifugation at 13,800 g for 2min. The pellet was collected
and washed twice with PBS. The pellet was resuspended in
500µL of 0.1% triton X-100 dissolved in PBS and then incubated
for 15min at 37◦C. 50µL of the reaction product was used for
detection following the instructions of β-galactosidase reporter
gene assay kit (Beyotime, China). Finally, the protein expressions
were detected using a micro plate reader at 450 nm.
In Vivo Experiments
All animal experiments were approved by the Ethics Committees
of Chongqing Medical University. Animals were anesthetized
with ethyl ether before any challenges or treatments to minimize
their suffering.
Female BALB/c mice (12–15 per group) aged 4–6 weeks were
used to evaluate the antimicrobial effects of the compounds
in vivo. In sepsis models, the mice were intraperitoneally infected
with 100µL S. pneumoniaeNCTC7466 strain suspension (1×103
CFU). An hour later, 100µL drugs at concentrations of 2mM (16
× MIC for compound 1, 8 × MIC for compound 4 and 32 ×
MIC for compound 5) or 4mM (32 × MIC for compound 2
and 64 × MIC for compound 3) were intraperitoneally injected
to the mice. These injections were continued, if the animals
did not die, thrice a day for 3 d. Two control groups were
injected with 100µL 1% DMSO (dissolved the drugs, negative
control) or PEN (0.42mg/kg/d, positive control) following the
same injection route. The result was expressed as cumulative
survival times following 7 d of observation.
In colonization models, the mice were intranasally challenged
by 20µL of clinical drug-resistant strains (pneumococcal
serotype 19F or 19A, 1.5 × 108 CFU). An hour later, the mice
were intraperitoneally injected with 100µL drugs (2 × MIC)
alone or in combination with PEN (2 × MIC). These injections
were continued thrice a day for 3 d. Nasal wash and lung tissues
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were obtained to analyze the bacteria load at 24, 48, and 72 h
after drug infection. Then 100µL aliquots of the samples diluted
were plated on blood agar plates. The colonies were counted after
incubation overnight at 37◦C with 5% CO2.
Statistical Analysis
All experiments were analyzed in three independent assays.
Data on the antimicrobial effects of the compounds in vivo
are shown as means ± SEM of two independent experiments.
Unless otherwise stated, statistical analyses of in vitro and in vivo
experiments were carried out using Student’s t-test (GraphPad
Prism 5). P < 0.05 was considered to indicate statistical
significance.
Results
Inhibitory Effects of the Five Compounds on the
ATPase Activity of Vick Protein
6 His-tagged VicK was expressed and purified by Ni2+ affinity
chromatography. To estimate the inhibitory effects of the
five compounds on VicK, purified VicK was incubated with
the compounds and its ATPase activity was determined in
presence of the compounds (Shuai et al., 2014). The results
FIGURE 2 | Inhibitory effects of the compounds on the ATPase activity
of VicK. The inhibitory potencies of the five compounds to VicK were
determined at varied concentrations (from 1.6 to 200µM). Error bars represent
the SEM from three independent assays.
showed that all five compounds inhibited the ATPase activity
of VicK in a dose-dependent manner (Figure 2). The IC50-
values of the five compounds were 3.8µM (1.12µg/mL), 5.4µM
(1.65µg/mL), 15.4µM (4.2µg/mL), 4.6µM (1.25µg/mL), and
9.1µM (3.07µg/mL), respectively. These results demonstrated
that each of the five compounds was capable to inhibit the ATPase
activity of VicK.
Antimicrobial Activity of the Five Compounds In
Vitro
The in vitro antimicrobial activities of the five compounds
and PEN against S. pneumoniae, PEN-resistant clinical strains
are summarized in Table 2. The five compounds displayed
an obvious antimicrobial effect against both PEN-susceptible
and PEN-resistant clinical strains. The MIC50 values of
deoxyshikonin and dodecyl gallate were 17 and 42µg/mL against
PEN-resistant strains, which were 8-fold and 4-fold lower than
those of other antimicrobial agents, respectively. These results
clearly showed that the five compounds were effective to inhibit
bacterial growth, even for strains resistant to PEN.
As far as we know, VicK is extremely conserved in the low
G + C content of gram-positive bacteria, such as Streptococcus
pyogenes (S. pyogenes), Streptococcusmitis (S. mitis), Streptococcus
mutans (S. mutans), and Streptococcus pseudopneumoniae (S.
pseudopneumoniae). Therefore, the antibacterial activities of
the five compounds against other gram-positive strains were
assayed in this work. As shown in Table 3, five compounds
all exhibited antibacterial effect against S. pyogenes, S. mitis,
S. mutans, S. pseudopneumoniae, and S. aureus. Importantly,
deoxyshikonin and dodecyl gallate also showed significantly
inhibitory activities against MRSA. These results demonstrated
that the five compounds, especially the deoxyshikonin and
dodecyl gallate, have broad-spectrum antibacterial effect against
gram-positive bacterial infections.
To further elucidate their antibacterial activities, a time-kill
assay was performed to observe the effect of five compounds
targeting VicK on bacterial growth. As expected, the five
compounds caused a maximum 5-log CFU reduction in S.
pneumoniae NCTC7466 (Figure 3) at MIC and four times the
MIC after 24 h of incubation. These results showed that the
five compounds have significant antibacterial activities against S.
pneumoniae in vitro.
TABLE 2 | In vitro inhibitory activities of the five compounds against pneumococcal strains.
Antimicrobial agent MIC of pneumococcal strains (µg/ml)
Penicillin susceptible (n = 7) Penicillin intermediate (n = 12) Penicillin resistant(n = 15)
Range MIC50 MIC90 Range MIC50 MIC90 Range MIC50 MIC90
5′-(Methylthio)-5′-deoxyadenosine 74–148 74 148 74–594 148 296 296.8–593.6 296.8 296.8
Octanal, 2-(2, 4-dinitrophenyl) hydrazone 76–152 152 152 38–154 77 154 77–616 308 616
Deoxyshikonin 17–34 17 34 34–196 68 196 8.5–136 17 68
Kavahin 34–272 68.5 136 68–518 137 274 68.5–548 274 548
Dodecylgallate 21–168 42 42 42–168 84 168 10.5–168.8 42 168.8
n, Indicates the strain numbers.
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TABLE 3 | Inhibitory activities of five compounds against streptococci and S. aureus assayed in vitro.
Bacteria (No. of isolates) MIC (µg/ml)
5′-(Methylthio)-5′-deoxyadenosine Octanal, 2-(2, 4-dinitrophenyl) hydrazone Deoxyshikonin Kavahin Dodecylgallate
S. pyogenes 148 308 8.5 274 42
S. mitis 148 308 125 274 338
S. mutans 594 616 34 274 42
S. pseudopneumoniae 148 154 136 34 42
Methicillin resistant S. aureus (4) –* – 34–68 – 84.4–336
MICs to inhibit the growth of 106CFU/ml bacteria were determined by the 2-fold agar dilution method.
*No antibacterial effect when the compounds were tested in the concentrations used in this study.
In Vivo Antimicrobial Activity
MTT assay (cc50) indicates that the five compounds displayed
low toxicity on Vero cells. The therapeutic efficacy of the five
compounds against S. pneumoniae was determined (Table 4)
in vivo. Generally, the mice infected with S. pneumoniae
NCTC7466 (1 × 103 CFU) could not survive more than 30 h
without any treatment. Compared with the negative control,
although these compounds could not reverse the fatal infection
of the concentration used in the present study, they were able to
significantly prolong the survival times of the infected mice (P <
0.05). Notably, the average survival time of the infected mice
was extended to 71 h following the treatment with the kavahin.
The results suggested that they may be good compounds in the
development of drugs against pneumococcal infection.
Synergic Antimicrobial Activity of the Five
Compounds and Pen in Vitro and in Vivo
Given that the five compounds were effective against PEN-
resistant clinical strains (Table 2), we determined whether these
compounds show synergism with PEN. We investigated the
antimicrobial effects of the compounds when combined with
PEN using the checkerboard test. Table 5 shows the combined
effects of the five compounds and PEN against PEN-resistant
S. pneumoniae and S. aureus. Although only deoxyshikonin
and Dodecyl gallate showed significantly synergic antimicrobial
activity with PEN against some PEN-resistant S. pneumoniae
with FICIs ranging from 0.17 to 0.34, all S. pneumoniae
organisms examined exhibited a 2-fold to 4-fold reduction
in MIC values after the treatment with the combination of
compound and PEN. Meanwhile, the MICs of deoxyshikonin or
dodecyl gallate in combination with PEN against the four strains
of MRSA showed a 2-fold reduction.
We also detected the combined effects of the five compounds
and Erythromycin/ Tetracycline against S. pneumoniae.
As shown in Table 6, Deoxyshikonin, Kavahin or Dodecyl
gallate showed significant synergic antimicrobial activity with
erythromycin against S. pneumoniae. Deoxyshikonin or Dodecyl
gallate showed significant synergic antimicrobial activity with
tetracycline against S. pneumoniae.
We selected deoxyshikonin and dodecyl gallate for further
evaluations because of their considerable synergistic antibacterial
activity with PEN. The efficacy of these compounds against two
clinical S. pneumoniae strains with a high incidence in children
was determined (Table 7). Deoxyshikonin and dodecyl gallate
caused a two-log reduction of 19A bacterial numbers and a
one-log reduction in 19F bacterial numbers at 24 h. The results
showed that deoxyshikonin and dodecyl gallate eliminated the
bacterial colonization in the nasopharynx and lung of mice
at 24 and 72 h after infection. In the 19A challenge model,
the group injected with dodecyl gallate plus PEN showed a 1-
fold reduction in log CFU bacterial load in the nasopharynx
within 48 h compared with penicillin/compound group. In the
19F challenge model, the joint groups (deoxyshikonin plus PEN
and dodecyl gallate plus PEN) showed a 1-log CFU and 1.5-
log CFU reduction in bacterial load in the nasopharynx within
48 and 72 h, respectively. These results are consistent with the
in vitro results and suggest that the two compounds can enhance
the sensitivity of bacteria to PEN and be used combination
with other antibiotic to combat the antibiotic-resistant bacteria
infection.
Effects of the Five Compounds on Cell Division
Phenotype
Barendt SM and Sham LT reported that VicK regulates the
division of bacterial cells. In this study, bacteria were exposed
to the agents at sub-MIC concentrations. Light microscopy
and electron microscopy results showed that some bacteria
became longer or thicker (Figures 4A5,A6,B2,B4), irregular or
with abnormal divisions (Figures 4A2–A4,B3,B5,B6). Based on
these findings, we detected the expression of FtsW which is
an essential membrane protein and is involved in bacterial
cell division (Dubrac et al., 2008). β-galactosidase activity
was used to report the expression level of FtsW (Figure 5).
In the control group, the expression of FtsW was increased
as the optical density of the bacteria increased. When the
strain was incubated with the five compounds, compared
with that in the control group, the expression of FtsW was
decreased regardless of the increase or decrease in growth
density. The results suggested that the antibacterial activity of
the five VicK inhibitors may partly attribute to the inhibition
of FtsW.
Inhibition of Biofilm Formation
A recent study has reported that more than 60% of all bacterial
infections in human are caused by microbial growth as biofilms,
which show low susceptibility to antimicrobial agents (Moscoso
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FIGURE 3 | Bactericidal activities of the five compounds against the strain S. pneumoniae NCTC7466.
et al., 2009). We determined the inhibitory activity of the five
compounds against biofilms at different concentrations (15.6–
2000µM). Crystal violet staining revealed that all the studied
compounds at MIC or sub-MIC levels inhibited the biofilm
formation of S. pneumoniae NCTC7466 (Figure 6A). It’s much
more impressive for Deoxyshikonin to inhibit biofilm formation
compared to other compounds. Crystal violet results were
confirmed by determining the biofilm OD (Figure 6B). The
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TABLE 4 | In vivo inhibitory activities of the five compounds against S. pneumoniae NCTC7466.
Compound Mean survival of mice ± SEM (hours) P-valueb Dose (mg/kg) cc50 mM
Untreated controla 28.8 ± 1.25
5′-(Methylthio)-5′-deoxyadenosine 49.5 ± 3.93 0.0062 97.2 >16 (336)
Octanal, 2-(2, 4-dinitrophenyl) hydrazone 42.1 ± 4.1 0.0053 50.4 >4 (<16)
Deoxyshikonin 50.6 ± 4.1 <0.0001 44.5 4.68 (<16)
Kavahin 71.1 ± 7.1 <0.0001 89.7 >8 (193)
Dodecylgallate 60.2 ± 7.3 0.0005 55.3 6.45 (29.5)
a Infected mice were treated with 1% DMSO (vol/vol) and 0.2% Tween 20 (vol/vol) in water.
bUnpaired t-test (vs. untreated control). P < 0.05 was considered significant.
TABLE 5 | In vitro inhibitory activity of five respective compounds in combination with penicillin against S. pneumoniae and S. aureus.
Strains MIC (µg/ml)
Agent Alone Compound + penicillin FICIa Outcome
S. pneumoniaeb
12092624 Compound1/Penicillin 296.8/3.56 148/0.19 0.55
Compound2/Penicillin 154/3.56 77/0.3 0.60
Compound3/Penicillin 136/3.56 34/0.19 0.30 Synergy
Compound4/Penicillin 274/3.56 137/0.19 0.55
Compound5/Penicillin 84.4/3.56 42/0.19 0.30 Synergy
736007 Compound1/Penicillin 296.8/7.1 148/2.67 0.87
Compound2/Penicillin 154/ 7.1 77/0.6 0.59
Compound3/Penicillin 136/7.1 34/0.6 0.34 Synergy
Compound4/Penicillin 274/7.1 137/0.6 0.59
Compound5/Penicillin 337/7.1 84/0.6 0.59
8364981 Compound1/Penicillin 148/3.56 74/3.1 1.37
Compound2/Penicillin 77/3.56 38.5/0.19 0.55
Compound3/Penicillin 136/3.56 62.5/0.19 0.17 Synergy
Compound4/Penicillin 548/3.56 137/0.38 0.26
Compound5/Penicillin 168/3.56 84/0.19 0.30 Synergy
652336 Compound1/Penicillin 296.8/4.4 148/0.22 0.55
Compound2/Penicillin 154/4.4 77/0.44 0.51
Compound3/Penicillin 136/4.4 17/0.22 0.30 Synergy
Compound4/Penicillin 548/4.4 274/0.44 0.51
Compound5/Penicillin 84.4/4.4 42.2/0.44 0.51
S. aureusc
ATCC29213 Compound3/Penicillin 34/52 17/4.4 0.58
Compound5/Penicillin 168/52 84/4.4 0.58
MRSA8506305 Compound3/Penicillin 34/6682 17/833 0.6
Compound5/Penicillin 337/6682 168/333 0.9
MRSA 8569082 Compound3/Penicillin 68/1667 34/208 0.60
Compound5/Penicillin 84.4/166 42.2/208 0.62
MRSA8548991 Compound3/Penicillin 34/3339 17/416 0.62
Compound5/Penicillin 84.4/3339 42/416 0.62
aSynergy is defined as FICI < 0.5; Antagonism is defined as FICI > 2.
bThe clinical strains 12092624, 736007, 8364981, 652336 were Penicillin-resistant S. pneumoniae strains.
cThe clinical isolates 8506305, 8569082, 8548991 were methicillin-resistant S. aureus strains. Compound1, 5′-(Methylthio)-5′-deoxyadenosine; Compound2, Octanal, 2-(2,
4-dinitrophenyl) hydrazone; Compound3, Deoxyshikonin; Compound4, Kavahin; Compound5, Dodecyl gallate.
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results clearly showed that the compounds have the capacity to
inhibit the development of biofilm formation.
Discussion and Conclusion
The emergence of S. pneumoniae strains resistant to carbapenem
and vancomycin which are important agents for the treatment
of gram-positive bacteria has become a global concern (Hanna-
Wakim et al., 2012). Commonly, conventional antibiotics were
designed based on their inhibitory effects against proteins with
essential functions. In this study, the five compounds show
an effective antimicrobial activity against the pneumococcus by
targeting the upstream regulatory proteins of TCSs. The present
work opens sights for the development of new therapeutic agents
that may be effective against multidrug-resistant bacteria (Cai
et al., 2002).
The active compounds of natural products are important
sources of new drugs, and it’s estimated that about half of
the clinical drugs stemmed from natural products and their
TABLE 6 | In vitro inhibitory activity of five respective compounds in
combination with erythromycin or tetracycline against S. pneumoniae.
Antimicrobial agent Erythromycin Tetracycline
FICI Outcome FICI Outcome
5′-(Methylthio)-5′-deoxyadenosine 2 0.9
Octanal, 2-(2, 4-dinitrophenyl) hydrazone 2 0.75
Deoxyshikonin 0.37 Synergy 0.125 Synergy
Kavahin 0.5 Synergy 0.51
Dodecylgallate 0.31 Synergy 0.18 Synergy
TABLE 7 | In vivo inhibitory activity of two compounds alone and combinations against clinical S. pneumoniae.
Strains Antimicrobial agent Dose(mg/kg/d) Mean log CFU at site of infectiona
NW (P-value) Lung (P-value)
24 h 48 h 72 h 24 h 48 h 72 h
19A Control 7.29 5.97 6.01 4.85 6.12 6.29
PEN 0.29 6.44 5.88 5.34 4.8 4.5 4.89
Deoxyshikonin 0.45 6.08 (0.026)b 2.76 (0.005)b 3 (0.011)b 1 2.39 (0.0001)b 1.05 (0.04)b
Dodecylgallate 0.57 5.91 (0.021)b 5.28 3.62 (0.033)b 1 3 2.82
Deoxyshikonin+PEN 5.82 4.2 3.36 1.61 4.15 3.43
Dodecylgallate+PEN 6.15 4.8 (0.04)c 3.35 1.61 2.25 (0.017)c 1.53
19F Control 6.72 6.27 7.09 2.82 7.57 4.95
PEN 0.16 6.21 2.1 6.12 1 2.58 3.22
Deoxyshikonin 0.45 3.30 4.6 (0.0002)b 5.52 (<0.0001)b 1 (<0.0001)b 1 (0.001)b 2.5 (<0.0001)b
Dodecylgallate 0.57 2.16 5.55 5.82 (<0.0001)b 3.9 (0.0001)b 3 (0.006)b 2.8 (<0.0001)b
Deoxyshikonin+PEN 6.27 3.1 (0.049)c 5.34 (0.02)c 3.57 1 2.39
Dodecylgallate+PEN 6.33 1.95 4.26 (0.004)c 7.5 3.45 2.51
aThe mice were intranasally infected clinical S. pneumoniae 19A (CMCC31689) and 19F (CMCC31693) (1.5× 108 CFU) in each group and received intraperitoneal injections of drugs
three times a day for 3 days. The numbers of bacteria in nasopharynx and lung were determined at 24, 48, and 72 h.
bDifferences between treated groups and controls were analyzed. P < 0.05 was considered significant.
cDifferences between treated groups versus Penicillin. P < 0.05 was considered significant.
derivatives. TCM has a wide variety of active ingredients for
discovering novel leading compounds. Several studies have
reported the screening of antibacterial drugs from Traditional
Chinese Medicines (Palacios-Espinosa et al., 2014). This is the
first time to describe a specific target-based screening and
identification of antibacterial compounds from TCM.
In the present study, we focus on the effects of the
five TCM monomers on phosphatase activity of VicK, their
antibacterial activity, their synergistic actions with penicillin.
In vitro inhibition assays show that all of the five compounds
can specifically inhibit the autophosphorylation of VicK protein
(Figure 2). We have previously reported the ATP binding site
of VicK consists of a hydrophobic inner cavity and a larger
hydrophilic outer cavity (Li et al., 2009). It seems that all of the
compounds share a common feature that they have a hydrophilic
part containing several –OH and/or –NH moieties that are
prone to form an intermolecular hydrogen bond; meanwhile, the
hydrophobic part of these compounds is able to enter into the
hydrophilic outer cavity of VicK. This may result in disorder of
the VicK activity.
As expected, antibacterial results show that all of the
five compounds have obvious inhibitory effects against S.
pneumoniae D39 strain which is susceptible to all kinds of
antibacterial agents (Figure 3). However, the emergency of drug-
resistant pneumococcal strains has complicated the clinical
treatment of pneumococcal infection. Therefore, we investigated
the activities of the five compounds against penicillin- resistant
S. pneumoniae (PRSP) strains in vitro (Table 2). The five
compounds had antibacterial effects on all tested strains.
Compared to the other three compounds, deoxyshikonin, and
dodecyl gallate were more effective against the tested strains,
including the important pathogen PRSP. These data indicate that
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FIGURE 4 | The effect of the compounds on cell division.
Mid-exponential grown cells of D39 were diluted (1:1000) and incubated in the
absence (1) or presence of compounds 1 (2), 2 (3), 3 (4), 4 (5), and 5 (6) for 5 h
at 37◦C. (A) Bacterial cells were observed by microscopy after staining with
leather blue dye solution. (B) Bacterial cell were observed by transmission
electron microscopy. Abnormal cells were indicated by black arrow.
the five compounds could be an effective alternative to treat drug-
resistant pneumococcal strains. In addition, we found that five
compounds were also effective against S. mutans, S. pyogenes, S.
mitis, and S. pseudopneumoniae (Table 3). The homology of VicK
protein in these bacteria with S. pneumoniae was up to 81–95%
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), which could be used to
explain why these compounds have a broad spectrum activity in
streptococci.
Although sequence alignment with BlastP demonstrated that
S. aureus VicK shares 68% amino acid similarity with its
counterparts in S. pneumoniae (http://blast.ncbi.nlm.nih.gov/
Blast.cgi), not all of the five compounds but deoxyshikonin
and dodecyl gallate inhibited the growth of S. aureus strains
(Table 2). We hypothesized that the center conformation of VicK
ATPase in S. aureus is different from that in streptococci and
hence led to the discrepancy in inhibition between S. aureus
and streptococci. However, it’s also possible that the target of
deoxyshikonin or dodecyl gallate may be not limited to VicK
FIGURE 5 | The effects of the five compounds on the expression of
FtsW. LacZ were used to report the expression of FtsW. The β-galactosidase
activities of the D39 (FtswLacZ) were determined following the treatment of the
compounds. Wild-type D39 and D39 (FtswLacZ) were served as negative
controls.
in S. aureus. Further studies are required to distinguish these
possibilities.
VicR/K can affect bacterial cell division by regulating the
expression of DacA, Pmp23, DacB, and FtsX in S. pneumoniae
(Dubrac et al., 2008; Sham et al., 2011). In the present study, we
observed that bacteria were defective in cell division following
treatment with the compounds (Figure 4). FtsW is also an
essential membrane protein involved in bacterial cell division,
and we showed that the expression of FtsW was impaired
following the treatment with the five compounds (Figure 5). The
data are in accordance with a regulation of FtsW by VicK. These
results indicate that the five VicK inhibitors could impair cell
division of the bacteria via FtsW.
Bacteria in biofilms are 100–1000 times more resistant to
antibiotics than planktonic cells (Kubo et al., 2003; Passerini
de Rossi et al., 2009). VicR/K can also regulate the bacterial
biofilms formation (Gupta and Kohli, 2003; Qin et al.,
2007; Mun et al., 2013). As expected, five compounds also
displayed strong bactericidal activities toward cells in biofilms.
Particularly, deoxyshikonin and dodecyl gallate could inhibit
biofilm formation at sub-MIC. A previous study reported that
S. pneumoniae TCS11 and TCS12 (comDE) were implicated in
the formation of biofilm (Cockeran et al., 2014; Galante et al.,
2015). HK11 and comD only show a discernable similarity
with VicK protein, and the similarity is less than 30% even
in regard to the ATPase domain. Thus, these compounds may
have, if any, a very limited effect on inhibition of the HK
of the two TCS, and biofilm inhibition by these compounds
may be primarily attributed to their inhibitory effect on VicK
protein.
Several studies have proposed that the combination of natural
compounds with antibiotics to treat infections caused by bacterial
species and natural plant products may potentiate the activity of
antibiotics (Garo et al., 2007). Their combinations may enhance
antibacterial efficacy and reduce the emergence of antibiotics-
resistant strains. Given that the different antibacterial mechanism
between the VicK inhibitors and the conventional antibiotics,
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FIGURE 6 | The effect of the compounds to inhibit the formation of the
bilofilm. (A) Biofilms were visualized by crystal violet staining. The formation
of biofilm can be seen in wells of bacteria treated with 1% DMSO (negative
control) and the well without adding anything served as blank. The images
are representative of results from three independent experiments. (B) The
absorbance of the wells at 590 nm was detected using a spectrophotometer.
The differences between the negative control (0µM antimicrobial
compounds) and antimicrobial-treated groups were statistically significant.
such as PEN, erythromycin and tetracycline, they are used in
combination to explore whether they have synergistic or additive
effects against pneumococcal infections. Our results showed that
deoxyshikonin or dodecyl gallate in combination with PEN
had synergistic activities against all the multidrug-resistant S.
pneumoniae strains in vitro (Table 5) and in vivo (Table 7).
However, the synergistic effect of the combinations of the
other three compounds with these antibiotics was not obvious.
Nevertheless, their MICs could be reduced, suggesting the
three compounds also have enhancement effects on antibiotics.
Interestingly, deoxyshikonin, kavahin, or dodecyl gallate showed
significant synergic antimicrobial activity with erythromycin
against S. pneumoniae (Table 6). S. pneumoniae is one of themost
important human pathogens in children. Erythromycin drugs
are the first choice for children allergic to penicillin. However,
the erythromycin resistance rate in S. pneumoniae isolates is
significantly high (Ma et al., 2013), thus, the three compounds
may have potential prospect to treat erythromycin resistant
bacteria.
These compounds significantly prolong the survival times of
mice infected with lethal dose of pneumococci in animal models
(Table 4). Dodecyl gallate was also effective against intranasal
infection with S. pneumoniae 19F strain, except that dodecyl
gallate-treated mice exhibited higher bacterial load in the lungs
than control mice at 24 h. It seems that in vivo antibacterial
activities were not always correlated with their MIC values, and
this may be explained by the fact that the antibacterial effects
of drugs may be affected by absorption, distribution metabolism
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and metabolism in vivo (Neve et al., 2013; Cõrte-Real et al.,
2014);. Therefore, to obtain more effective inhibitors, structural
modification of these compounds may be required in the future
work.
Protein phosphorylation signal transduction system is
widespread in bacteria, such as Ser/Thr/Tyr phosphorylation.
Bacterial tyrosine kinases would be a promising target for the
screening of antibacterial drugs since they do not share any
similarity with those of eukaryote. A recent report shows that
phosphorylation of proteins in carbapenem resistant strains of
A. baumannii is significantly higher than that in carbapenem
sensitive strains (Tiwari and Tiwari, 2015). Thus, targeting
the kinase may provide a potentially useful way to discover
antimicrobial compounds that are effective against antimicrobial
agents-resistant bacteria. Together with our data support
the concept that it would be useful to screen the potential
antibacterial drugs by targeting kinases.
Taken together, the present study provides preclinical
evidence of the efficacies of the five lead compounds against the
pneumococcus and other gram-positive bacteria. These novel
antibacterial agents may serve as an alternative strategy for the
treatment of bacterial infections.
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